This study aimed to assess the functional results of a new, active, acoustic-mechanical hearing implant, the Direct Acoustic Cochlear Stimulation Partial Implant (DACS PI), in a preclinical study. The DACS PI is an electromagnetic device fixed to the mastoid by screws and coupled to a standard stapes prosthesis by an artificial incus (AI). The function of the DACS PI-aided reconstruction was assessed by determining: (1) the maximum equivalent sound pressure level (SPL) of the implant, which was obtained from measurements of the volume displacement at the round window in normal and implanted ears, and (2) the quality at the coupling interface between the AI of the DACS and the stapes prosthesis, which was quantified from measurements of relative motions between the AI and the prosthesis. Both measurements were performed with fresh temporal bones using a scanning laser Doppler interferometry system. The expected maximum equivalent SPL with a typical driving voltage of 0.3 V was about 115–125 dB SPL up to 1.5 kHz in reconstruction with the DACS PI, and decreased with a roll-off slope of about 65 dB/decade, reaching 90 dB SPL at 8 kHz. The large roll-off relative to a normal ear was presumed to be a relatively high inductive impedance of the coil of the DACS PI actuator at higher frequencies. Good coupling quality between the AI and the prosthesis was achieved below the resonance (∼1.5 kHz) of the DACS PI for all tested stapes prostheses. Above the resonance, the SMart Piston, which is composed of a shape-memory alloy, had the best coupling quality.

1.
American Society for Testing and Materials (ASTM) International F2504-05 Standard Practice for Describing System Output of Implantable Middle Ear Hearing Devices. Philadelphia, ASTM, 2005.
2.
Babighian G, Fontana M, Caltran S, Ciccolella M, Amadori M, De Zen M: The heat-activated stapes prosthesis ‘SMart’ Piston: technique and preliminary results. Adv Otorhinolaryngol 2007;65:190–196.
3.
Bernhard H, Stieger C, Perriard Y: New implantable hearing device based on a micro-actuator that is directly coupled to the inner ear fluid. Conf Proc IEEE Eng Med Biol Soc 2006;1:3162–3165.
4.
Gopen Q, Rosowski JJ, Merchant SN: Anatomy of the normal human cochlear aqueduct with functional implications. Hear Res 1997;107:9–22.
5.
Häusler R, Stieger C, Bernhard H, Kompis M: A novel implantable hearing system with direct acoustic cochlear stimulation. Audiol Neurotol 2008;13:247–256.
6.
Huber AM, Veraguth D, Schmid S, Roth T, Eiber A: Tight stapes prosthesis fixation leads to better functional results in otosclerosis surgery. Otol Neurotol 2008;29:893–899.
7.
Rajan GP, Atlas MD, Subramaniam K, Eikelboom RH: Eliminating the limitations of manual crimping in stapes surgery? A preliminary trial with the shape memory Nitinol stapes piston. Laryngoscope 2005;115:366–369.
8.
Rosowski JJ, Songer JE, Nakajima HH, Brinsko KM, Merchant SN: Clinical, experimental, and theoretical investigations of the effect of superior semicircular canal dehiscence on hearing mechanisms. Otol Neurotol 2004;25:323–332.
9.
Rosowski JJ, Chien W, Ravicz ME, Merchant SN: Testing a method for quantifying the output of implantable middle ear hearing devices. Audiol Neurotol 2007;12:265–276.
10.
Sim JH, Chatzimichalis M, Huber AM: The influence of postoperative tissue formation on sound transmission after stapes surgery. Hear Res 2010;263:38–42.
11.
Sim JH, Chatzimichalis M, Röösli C, Laske R, Huber AM: Objective assessment of stapes surgery from round window motion measurement. Ear Hear 2012, in print (DOI: 10.1097/AUD.0b013e318258c7a6).
12.
Stenfelt S, Hato N, Goode RL: Fluid volume displacement at the oval and round windows with air and bone conduction stimulation. J Acoust Soc Am 2004;115:797–812.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.